{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:41:20Z","timestamp":1773952880169,"version":"3.50.1"},"reference-count":35,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2019.1952","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T07:46:07Z","timestamp":1574235967000},"source":"Crossref","is-referenced-by-count":9,"title":["Induction of G0\/G1\ufffdphase arrest and apoptosis by CRISPR\/Cas9\u2011mediated knockout of CDK2 in A375 melanocytes"],"prefix":"10.3892","author":[{"given":"Houguang","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Third Hospital of Xiamen, Xiamen, Fujian 361100, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Third Hospital of Xiamen, Xiamen, Fujian 361100, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Huo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Third Hospital of Xiamen, Xiamen, Fujian 361100, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongling","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Third Hospital of Xiamen, Xiamen, Fujian 361100, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Third Hospital of Xiamen, Xiamen, Fujian 361100, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"key":"key20200713202634_b1-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.det.2012.04.001","article-title":"Update on the current state of melanoma incidence","volume":"30","author":"Little","year":"2012","journal-title":"Dermatol Clin"},{"key":"key20200713202634_b2-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.fsc.2018.08.003","article-title":"Management of early-stage melanoma","volume":"27","author":"Quintanilla-Dieck","year":"2019","journal-title":"Facial Plast Surg Clin North Am"},{"key":"key20200713202634_b3-mco-0-0-1952","first-page":"591","article-title":"Vital signs: Melanoma incidence and mortality trends and projections-United States, 1982\u20132030","volume":"64","author":"Guy","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key20200713202634_b4-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jaad.2014.06.044","article-title":"Adequacy of 5-mm surgical excision margins for non-lentiginous melanoma in situ","volume":"71","author":"Duffy","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"key20200713202634_b5-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1524-4725.2009.01421.x","article-title":"Use of reflectance confocal microscopy to monitor response of lentigo maligna to nonsurgical treatment","volume":"36","author":"Nadiminti","year":"2010","journal-title":"Dermatol Surg"},{"key":"key20200713202634_b6-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/2594","article-title":"Understanding the cell cycle","volume":"4","author":"Nurse","year":"1998","journal-title":"Nat Med"},{"key":"key20200713202634_b7-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1098\/rstb.2011.0274","article-title":"The cell cycle","volume":"366","author":"Hunt","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key20200713202634_b8-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1152\/physrev.00025.2010","article-title":"Physiological relevance of cell cycle kinases","volume":"91","author":"Malumbres","year":"2011","journal-title":"Physiol Rev"},{"key":"key20200713202634_b9-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1023\/A:1022077317801","article-title":"Nobel Lecture. Protein synthesis, proteolysis, and cell cycle transitions","volume":"22","author":"Hunt","year":"2002","journal-title":"Biosci Rep"},{"key":"key20200713202634_b10-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.molcel.2011.03.031","article-title":"Switching Cdk2 on or off with small molecules to reveal requirements in human cell proliferation","volume":"42","author":"Merrick","year":"2011","journal-title":"Mol Cell"},{"key":"key20200713202634_b11-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0092-8674(00)80994-0","article-title":"Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity","volume":"84","author":"Guadagno","year":"1996","journal-title":"Cell"},{"key":"key20200713202634_b12-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1038\/onc.2016.409","article-title":"A CDK2 activity signature predicts outcome in CDK2-low cancers","volume":"36","author":"McCurdy","year":"2017","journal-title":"Oncogene"},{"key":"key20200713202634_b13-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/0929867321666141106113633","article-title":"Cyclin-dependent kinase-2 as a target for cancer therapy: Progress in the development of CDK2 inhibitors as anti-cancer agents","volume":"22","author":"Chohan","year":"2015","journal-title":"Curr Med Chem"},{"key":"key20200713202634_b14-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1535-6108(03)00053-9","article-title":"Proliferation of cancer cells despite CDK2 inhibition","volume":"3","author":"Tetsu","year":"2003","journal-title":"Cancer Cell"},{"key":"key20200713202634_b15-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1083\/jcb.200702034","article-title":"An essential role for Cdk1 in S phase control is revealed via chemical genetics in vertebrate cells","volume":"178","author":"Hochegger","year":"2007","journal-title":"J Cell Biol"},{"key":"key20200713202634_b16-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.cub.2003.09.024","article-title":"Cdk2 knockout mice are viable","volume":"13","author":"Berthet","year":"2003","journal-title":"Curr Biol"},{"key":"key20200713202634_b17-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/1947601913479799","article-title":"Mammalian interphase cdks: Dispensable master regulators of the cell cycle","volume":"3","author":"Enders","year":"2012","journal-title":"Genes Cancer"},{"key":"key20200713202634_b18-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4939-8967-6_10","article-title":"Genome-wide CRISPR\/Cas9 screening for identification of cancer genes in cell lines","volume":"1907","author":"Adelmann","year":"2019","journal-title":"Methods Mol Biol"},{"key":"key20200713202634_b19-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-1-4939-8967-6_11","article-title":"CRISPR\/Cas9-based positive screens for cancer-related traits","volume":"1907","author":"Slipek","year":"2019","journal-title":"Methods Mol Biol"},{"key":"key20200713202634_b20-mco-0-0-1952","first-page":"6345","article-title":"Apoptosis of human melanoma A375 cells induced by lentivirus mediated CDK2-shRNA","volume":"35","author":"Liu","year":"2015","journal-title":"Chin J Gerontol"},{"key":"key20200713202634_b21-mco-0-0-1952","first-page":"135","article-title":"Apoptosis of human melanoma A375 cells induced by adenovirus-associated virus mediated CDK2-shRNA","volume":"30","author":"Liu","year":"2015","journal-title":"Chin J Control Endemic Dis"},{"key":"key20200713202634_b22-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713202634_b23-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"6801","DOI":"10.3892\/mmr.2015.4261","article-title":"Knockdown of myosin VI by lentivirus-mediated short hairpin RNA suppresses proliferation of melanoma","volume":"12","author":"Li","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20200713202634_b24-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jdermsci.2015.03.020","article-title":"RNAi-mediated downregulation of CDKL1 inhibits growth and colony-formation ability, promotes apoptosis of human melanoma cells","volume":"79","author":"Song","year":"2015","journal-title":"J Dermatol Sci"},{"key":"key20200713202634_b25-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.biopha.2018.12.048","article-title":"CRISPR\/Cas9-mediated knockout of the PDEF gene inhibits migration and invasion of human gastric cancer AGS cells","volume":"111","author":"Zhang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"key20200713202634_b26-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/hum.2015.067","article-title":"CRISPR\/Cas9-mediated genome editing of epigenetic factors for cancer therapy","volume":"26","author":"Yao","year":"2015","journal-title":"Hum Gene Ther"},{"key":"key20200713202634_b27-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1159\/000486168","article-title":"Oncogenic human papillomavirus: Application of CRISPR\/Cas9 therapeutic strategies for cervical cancer","volume":"44","author":"Zhen","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"key20200713202634_b28-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13036-018-0127-2","article-title":"Delivery systems of CRISPR\/Cas9-based cancer gene therapy","volume":"12","author":"Biagioni","year":"2018","journal-title":"J Biol Eng"},{"key":"key20200713202634_b29-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccr.2005.05.006","article-title":"Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1)","volume":"7","author":"Mart\u00edn","year":"2005","journal-title":"Cancer Cell"},{"key":"key20200713202634_b30-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/onc.2015.175","article-title":"Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4\/c-Fos signaling pathway","volume":"35","author":"Peng","year":"2016","journal-title":"Oncogene"},{"key":"key20200713202634_b31-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"13429","DOI":"10.1038\/s41598-017-12868-5","article-title":"Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage","volume":"7","author":"Bacevic","year":"2017","journal-title":"Sci Rep"},{"key":"key20200713202634_b32-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"key20200713202634_b33-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nbt.2800","article-title":"Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library","volume":"32","author":"Koike-Yusa","year":"2014","journal-title":"Nat Biotechnol"},{"key":"key20200713202634_b34-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: Changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ"},{"key":"key20200713202634_b35-mco-0-0-1952","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/cdd.2017.161","article-title":"The BCL-2 arbiters of apoptosis and their growing role as cancer targets","volume":"25","author":"Adams","year":"2018","journal-title":"Cell Death Differ"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:26:42Z","timestamp":1594668402000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2019.1952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":35,"URL":"https:\/\/doi.org\/10.3892\/mco.2019.1952","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]}}}